natgillin/translations-raw huggingface dataset:
- Hvis du har sprunget over mere end 7 dages behandling med Fycompa, skal du straks kontakte lægen. 
- If you have missed more than 7 days of treatment with Fycompa, talk to your doctor immediately.
- Hvis du drikker alkohol, mens du tager Fycompa, kan det også forstærke vredesudbrud, forvirring og nedtrykthed. 
- Drinking alcohol while taking Fycompa can also make any feelings of anger, confusion or sadness worse.
- Fycompa kan forårsage en øget faldtendens, især hvis du er en ældre person. 
- Fycompa may make you more likely to fall over, particularly if you are an older person; this might be due to your illness.
I kliniske studier blev aggression, vrede og irritabilitet rapporteret hyppigere hos perampanelbehandlede patienter ved højere doser. 
In perampanel-treated patients in clinical trials, aggression, anger and irritability were reported more frequently at higher doses.
Perampanel er en first-in-class selektiv, nonkompetitiv antagonist for den inotrope α-amino-3hydroxy-5-methyl-4-isoxazol-propionsyre (AMPA)-glutamatreceptor på postsynaptiske neuroner. 
Perampanel is a first-in-class selective, non-competitive antagonist of the ionotropic α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor on post-synaptic neurons.
Perampanel kan forårsage svimmelhed og døsighed, og derfor kan det påvirke evnen til at føre motorkøretøj eller betjene maskiner. 
Perampanel may cause dizziness and somnolence and, therefore, may influence the ability to drive or use machines.
I en populationsfarmakokinetisk analyse af de unge patienter med puljede resultater fra fase 2 og 3 kliniske studier var der ingen bemærkelsesværdig forskel mellem denne population og den samlede population. 
In a population pharmacokinetic analysis of the adolescent patients pooled from the Phase 2 and 3 clinical studies, there were no notable differences between this population and the overall population.
Aggression Vrede 
Aggression Anger
Patienterne bør optitreres med 2 mg (4 ml) doser, ikke hurtigere end hver 2. uge baseret på tolerabilitet og virkning. 
Patients should be up-titrated using 2 mg (4 ml) doses no faster than every 2 weeks based on tolerability and effectiveness.
For patienter med let eller moderat nedsat leverfunktion kan doseringen påbegyndes med 2 mg. 
For patients with mild or moderate hepatic impairment, dosing can be initiated at 2 mg.
Den mediane procentvise ændring i hyppigheden af primære generaliserede tonisk-klonisk krampeanfald pr. 28 dage i løbet af titrerings- og vedligeholdelsesperioderne (kombineret), relativt til præ-randomisering, var større med perampanel (-76,5 %) end med placebo (-38,4 %), p<0,0001. 
The median percent change in primary generalised tonic-clonic seizure frequency per 28 days during the Titration and Maintenance Periods (combined) relative to Prerandomisation was greater with perampanel (-76.5%) than with placebo (-38.4%), P < 0.0001.
Carmellosenatrium (E466) 
Carmellose sodium (E466)
Hvis du tager Fycompa sammen med andre lægemidler mod epilepsi, der indeholder sorbitol, kan det påvirke deres virkning. 
Taking Fycompa with other anti-epileptic medicine, which contains sorbitol, may affect how much they work.
I løbet af den 3 måneder lange vedligeholdelsesperiode holdt 30,9 % (25/81) af patienterne, der fik perampanel i de kliniske studier, op med at få PGTC-krampeanfald, sammenlignet med 12,3 % (10/81) i placebogruppen. 
During the 3 months maintenance period, 30.9% (25/81) of the patients on perampanel in the clinical studies became free of PGTC seizures compared with 12.3% (10/81) on placebo.
Virkning af CYP-hæmmere på farmakokinetikken af perampanel Hos raske personer forøgede CYP3A4-hæmmeren ketoconazol (400 mg én gang dagligt i 10 dage) perampanel AUC med 20 %, og det forlængede halveringstiden af perampanel med 15 % (67,8 t vs. 58,4 t). 
In healthy subjects, the CYP3A4 inhibitor ketoconazole (400 mg once daily for 10 days) increased perampanel AUC by 20% and prolonged perampanel half--life by 15% (67.8 h vs 58.4 h).
Der var ingen virkning på hannernes fertilitet. 
There were no effects on male fertility.
Perampanel kan forårsage svimmelhed og døsighed, og derfor kan det påvirke evnen til at føre motorkøretøj eller betjene maskiner (se pkt. 
Perampanel may cause dizziness and somnolence and therefore may influence the ability to drive or use machines (see section 4.7).
For patienter med let eller moderat nedsat leverfunktion kan doseringen påbegyndes med 2 mg (4 ml). 
For patients with mild or moderate hepatic impairment, dosing can be initiated at 2 mg (4 ml).
Filmovertræk (2 mg, 4 mg, 6 mg, 8 mg, 10 mg og 12 mg tabletter) Hypromellose 2910, talcum, macrogol 8000, titandioxid (E171), farvestoffer* 
Film coating (2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg tablets) Hypromellose 2910, talc, Macrogol 8000, titanium dioxide (E171), colourants*
Samtidige CYP3A-inducerende antiepileptika 
Concomitant CYP 3A inducing anti-epileptic medicinal products
Lad adapteren blive på, plads og sæt igen låget på flasken. 
8 Leave the adaptor in place and replace cap on bottle.
Den bivirkning, der hyppigst (≥2 % i perampanelgruppen og større end placebo) førte til seponering, var svimmelhed. 
The adverse reaction most commonly leading to discontinuation (≥ 2% in the perampanel group and greater than placebo) was dizziness.
Fycompa er indiceret som tillægsbehandling af primært generaliserede tonisk-kloniske anfald hos voksne og unge patienter fra 12 år med idiopatisk generaliseret epilepsi (se pkt. 
Fycompa is indicated for the adjunctive treatment of primary generalised tonic-clonic seizures in adult and adolescent patients from 12 years of age with idiopathic generalised epilepsy (see section 5.1).
Lactosemonohydrat, lavsubstitueret hydroxypropylcellulose, povidon, magnesiumstearat (E470b) 
Lactose monohydrate, low-substituted hydroxypropyl cellulose, povidone, magnesium stearate (E470b)
Flere doser af perampanel 12 mg/dag forøgede niveauerne af vredesudbrud, forvirring og depression, som vurderet ved 5-punkts-skalaen Profile of Mood State (se pkt. 
Multiple dosing of perampanel 12 mg/day increased levels of anger, confusion, and depression as assessed using the Profile of Mood State 5-point rating scale (see section 5.1).
I de kontrollerede fase 3 kliniske studier af partielle anfald var seponeringshyppigheden på grund af en bivirkning 1,7 %, 4,2 % og 13,7 % hos patienter, der blev randomiseret til at få perampanel med de anbefalede doser på hhv. 4 mg, 8 mg og 12 mg/dag, og 1,4 % hos patienter, der blev randomiseret til placebo. 
In the controlled Phase 3 partial-onset seizures clinical trials, the rate of discontinuation as a result of an adverse reaction was 1.7%, 4.2% and 13.7% in patients randomised to receive perampanel at the recommended doses of 4 mg, 8 mg and 12 mg/day, respectively, and 1.4% in patients randomised to receive placebo.
7 filmovertrukne tabletter 28 filmovertrukne tabletter 98 filmovertrukne tabletter 
7 film-coated tablets 28 film-coated tablets 98 film-coated tablets
Fycompa indeholder: - Aktivt stof: Perampanel. 
What Fycompa contains - The active substance is perampanel.
Brug af anden medicin sammen med Fycompa 
Other medicines and Fycompa
I det kontrollerede kliniske fase 3-studie af primært generaliserede tonisk-kloniske anfald var seponeringshyppigheden som et resultat af en bivirkning 4,9 % hos patienter, der blev randomiseret til at få perampanel 8 mg, og 1,2 % hos patienter, der blev randomiseret til placebo. 
In the controlled Phase 3 primary generalised tonic-clonic seizures clinical trial, the rate of discontinuation as a result of an adverse reaction was 4.9% in patients randomised to receive perampanel 8 mg, and 1.2% in patients randomised to receive placebo.
Der var ingen virkning på hannernes fertilitet (se pkt. 
There were no effects on male fertility (see section 5.3).
Fycompa 0,5 mg/ml oral suspension er en hvid til off-white suspension. 
What Fycompa looks like and contents of the pack Fycompa 0.5 mg/ml oral suspension is a white to off-white suspension.
- Hvis du har sprunget over færre end 7 dages behandling med Fycompa, skal du fortsætte med at tage din daglige tablet, som du oprindeligt blev anvist af lægen. 
- If you have missed less than 7 days of treatment with Fycompa, continue taking your daily tablet as originally instructed by your doctor.
- Det anvendes også til at behandle visse anfald, der påvirker hele din hjerne fra starten (det kaldes 
- It is also used to treat certain fits that affect all of your brain from the start (called “generalised seizures”) and cause convulsions or staring spells.
Gangforstyrrelser Træthed 
Gait disturbance Fatigue
Alle anfald holdt op hos 23,5 % (19/81) af patienterne i perampanel-gruppen sammenlignet med 4,9 % (4/81) i placebogruppen. 
Freedom from all seizures was achieved in 23.5% (19/81) of patients on perampanel compared to 4.9% (4/81) of patients on placebo.
- Øvrige indholdsstoffer: Sorbitol (E420) flydende (krystalliserende), mikrokrystallinsk cellulose (E460), carmellosenatrium (E466), poloxamer 188, simeticon- emulsion 30 % (indeholdende renset vand, siliconeolie, polysorbat 65, methylcellulose, silica-gel, macrogolstearat, sorbinsyre, benzoesyre og svovlsyre), citronsyre, vandfri (E330), natriumbenzoat (E211) og renset vand. 
- The other ingredients are sorbitol (E420) liquid (crystallising), microcrystalline cellulose (E460), carmellose sodium (E466), poloxamer 188, simethicone emulsion 30% (containing purified water, silicone oil, polysorbate 65, methylcellulose, silica gel, macrogol stearate, sorbic acid, benzoic acid and sulfuric acid), citric acid, anhydrous (E330), sodium benzoate (E211) and purified water.
8 mg tablet: Jernoxid, rød (E172), jernoxid, sort (E172) 10 mg tablet: Jernoxid, gul (E172), FD&C Blue #2 Indigo carmine aluminium lake (E132) 12 mg tablet: FD&C Blue #2 Indigo carmine aluminium lake (E132) 
8 mg tablet: Ferric Oxide, Red (E172), Ferric Oxide, Black (E172) 10 mg tablet: Ferric Oxide, Yellow (E172), FD&C Blue #2 Indigo carmine aluminium lake (E132) 12 mg tablet: FD&C Blue #2 Indigo carmine aluminium lake (E132)
Simeticon-emulsion 30 %, indeholdende renset vand, siliconeolie, polysorbat 65, methylcellulose, silica-gel, macrogolstearat, sorbinsyre, benzoesyre og svovlsyre Citronsyre, vandfri (E330) 
Simethicone emulsion 30%, containing purified water, silicone oil, polysorbate 65, methylcellulose, silica gel, macrogol stearate, sorbic acid, benzoic acid and sulfuric acid Citric acid, anhydrous (E330)
Hver flaske (340 ml) indeholder 170 mg perampanel. 
1 bottle (340 ml) contains 170 mg perampanel.
- Hvis du har sprunget over færre end 7 dages behandling med Fycompa, skal du fortsætte med at tage din daglige dosis, som du oprindeligt blev anvist af lægen. 
- If you have missed less than 7 days of treatment with Fycompa, continue taking your daily dose as originally instructed by your doctor.
Fycompa 2 mg filmovertrukne tabletter Pakning med 7, kun til den første uges dosering, 28 og 98. 
Fycompa 2 mg film-coated tablets Pack of 7 only for first week of dosing, 28 and 98
- Fycompa bør ikke anvendes under graviditeten. 
- Fycompa is not recommended in pregnancy.
Andre undertyper af idiopatisk generaliseret epilepsi Perampanels virkning og sikkerhed hos patienter med myokloniske anfald er ikke klarlagt. 
The efficacy and safety of perampanel in patients with myoclonic seizures have not been established.
Fycompa anses ikke for at være en potent induktor eller hæmmer af CYP- eller UGT-enzymer (se pkt. 
Fycompa is not considered a strong inducer or inhibitor of cytochrome P450 or UGT enzymes (see section 5.2).
1,7-5,8 % af patienterne, der fik perampanel i de kliniske studier, havde ikke epilepsianfald i løbet af den 3-måneders vedligeholdelsesperiode, sammenlignet med 0-1,0 % i placebogruppen. 
1.7 to 5.8% of the patients on perampanel in the clinical studies became seizure free during the 3 month maintenance period compared with 0%-1.0% on placebo.
I studie 332 stoppede anfaldene hos patienter med PGTC-anfald, der også havde samtidige myokloniske anfald, hos 16,7 % (4/24) af patienterne i perampanel-gruppen sammenlignet med 13,0 % (3/23) i placebogruppen. 
In Study 332, in patients with PGTC seizures who also had concomitant myoclonic seizures, freedom from seizures was achieved in 16.7% (4/24) on perampanel compared to 13.0% (3/23) in those on placebo.
Perampanel som tillægsbehandling hos patienter i alderen 12 år og derover med idiopatisk generaliseret epilepsi, der oplever primært generaliserede tonisk-kloniske anfald, blev undersøgt i et randomiseret, dobbeltblindet, placebokontrolleret multicenterstudie (studie 332). 
Perampanel as adjunctive therapy in patients 12 years of age and older with idiopathic generalised epilepsy experiencing primary generalised tonic-clonic seizures was established in a multicenter, randomised, double-blind, placebo-controlled study (Study 332).
7 filmovertrukne tabletter 28 filmovertrukne tabletter 84 filmovertrukne tabletter 98 filmovertrukne tabletter 
7 film-coated tablets 28 film-coated tablets 84 film-coated tablets 98 film-coated tablets
Hver filmovertrukket tablet indeholder 2 mg, 4 mg, 6 mg, 8 mg, 10 mg eller 12 mg perampanel. 
Each film-coated tablet contains 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, or 12 mg perampanel.
Hos patienter med samtidige absenceanfald stoppede anfaldene hos 22,2 % (6/27) af patienterne i perampanel-gruppen sammenlignet med 12,1 % (4/33) i placebogruppen. 
In patients with concomitant absence seizures, freedom from seizures was achieved in 22.2% (6/27) on perampanel compared to 12.1% (4/33) on placebo.
Tabletkerne (6 mg, 8 mg, 10 mg og 12 mg tabletter) Lactosemonohydrat, lavsubstitueret hydroxypropylcellulose, povidon, mikrokrystallinsk cellulose, magnesiumstearat (E470b) 
Tablet core (6 mg, 8 mg, 10 mg and 12 mg tablets) Lactose monohydrate, low-substituted hydroxypropyl cellulose, povidone, microcrystalline cellulose, magnesium stearate (E470b)
2 mg tablet - pakning med 7, 28 og 98 
2 mg tablet - pack of 7, 28 and 98
Kartoner med 7, 28, 84 og 98 tabletter 
Cartons of 7, 28, 84 and 98 tablets
Behandling med Fycompa bør påbegyndes med en dosis på 2 mg/dag. 
Treatment with Fycompa should be initiated with a dose of 2 mg/day.
Det skal du vide, før du begynder at tage Fycompa 
What you need to know before you take Fycompa
Karton med 7, 28 og 98 tabletter 
Carton of 7, 28 and 98 tablets
4 mg, 6 mg, 8 mg, 10 mg, 12 mg tabletter - pakninger med 7, 28, 84 og 98 
4 mg, 6 mg, 8 mg, 10 mg, 12 mg tablets - packs of 7, 28, 84 and 98
Hver flaske med 340 ml indeholder 170 mg perampanel. 
Each bottle of 340 ml contains 170 mg perampanel
Svimmelhed Døsighed 
Dizziness Somnolence
Svære kutane bivirkninger (SCARs), herunder lægemiddelfremkaldt reaktion med eosinofili og systemiske symptomer (DRESS) 
Severe cutaneous adverse reactions (SCARs) including drug reaction with eosinophilia and systemic symptoms (DRESS)
Fortæl altid lægen eller apotekspersonalet, hvis du tager anden medicin eller har gjort det for nylig. 
Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.
Brug den medfølgende orale sprøjte og adapter til dosering. 
For dosing please use the oral syringe and adaptor provided.
Fortæl altid lægen, hvis du tager disse former for medicin eller har gjort det for nylig, da det kan være nødvendigt at justere din dosis. 
Tell your doctor if you are taking or have recently taken these medicines as your dose may need to be adjusted.
Behandling med Fycompa bør påbegyndes med en dosis på 2 mg/dag (4 ml/dag). 
Treatment with Fycompa should be initiated with a dose of 2 mg/day (4 ml/day).
Da en enkeltdosis på 12 mg af begge formuleringer blev administreret sammen med et måltid med et højt fedtindhold, opnåede perampanel oral suspension en ækvivalent AUC0-inf og en ca. 23 % lavere Cmax og en 2-timers forsinkelse i tiden til den maksimale eksponering (tmax) sammenlignet med tabletformuleringen. 
perampanel oral suspension achieves equivalent AUC0-inf and approximately 23 % lower Cmax and 2 hours delay in time to peak exposure (tmax) compared to the tablet formulation.
Perampanel elimineres næsten udelukkende ved metabolisme efterfulgt af en hurtig udskillelse af metabolitterne. 
Perampanel is eliminated almost exclusively by metabolism followed by rapid excretion of metabolites; only trace amounts of perampanel metabolites are observed in plasma.
Afhængig af individuelt klinisk respons og tolerabilitet, kan dosis øges eller nedsættes i trin på 2 mg (se pkt. 
Depending upon individual clinical response and tolerability, the dose may be increased or decreased 2 mg at a time (see section 4.2).
I en populationsfarmakokinetisk analyse af patienter med partielle anfald, der havde kreatinin-clearance i intervallet fra 39 til 160 ml/min og fik perampanel op til 12 mg/dag i placebokontrollerede kliniske studier, var perampanel-clearance ikke påvirket af kreatinin-clearance. 
In a population pharmacokinetic analysis of patients with partial-onset seizures having creatinine clearances ranging from 39 to 160 mL/min and receiving perampanel up to 12 mg/day in placebo-controlled clinical trials, perampanel clearance was not influenced by creatinine clearance.
Tag Fycompa, så længe som lægen anbefaler det. Du må ikke holde op, medmindre lægen anviser det. Din læge kan gradvist reducere din dosis, så du undgår, at dine anfald (epileptiske anfald) vender tilbage eller forværres. 
Your doctor may reduce your dose slowly to avoid your fits (seizures) coming back or getting worse.
6 mg tablet: Jernoxid, rød (E172) 
6 mg tablet: Ferric Oxide, Red (E172)
I alle tre studier blev personerne randomiseret og titreret til den randomiserede dosis efter en 6-ugers baselinefase, der havde til formål at etablere hyppigheden af epilepsianfald ved baseline før randomisering. 
In all three trials, following a 6-week Baseline Phase to establish baseline seizure frequency prior to randomisation, subjects were randomised and titrated to the randomised dose.
I en populationsfarmakokinetisk analyse af patienter med primært generaliserede tonisk-kloniske anfald, der fik perampanel op til 8 mg/dag i et placebokontrolleret klinisk studie, var perampanel-clearance ikke påvirket af kreatinin-clearance ved baseline. 
In a population pharmacokinetic analysis of patients with primary generalised tonic-clonic seizures receiving perampanel up to 8 mg/day in a placebo-controlled clinical study, perampanel clearance was not influenced by baseline creatinine clearance.
Alvorlige hudreaktioner, herunder lægemiddelfremkaldt reaktion med eosinofili og systemiske symptomer (DRESS), er rapporteret i forbindelse med brugen af perampanel. 
Serious skin reactions including drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported with the use of perampanel.
CYP-induktorers indvirkning på perampanels farmakokinetik 
Effect of cytochrome P450 inducers on perampanel pharmacokinetics
Andre samtidige (ikke-antiepileptiske) CYP-inducerende eller -hæmmende lægemidler 
Other concomitant (non- anti-epileptic) cytochrome P450 inducing or inhibiting medicinal products
I en populationsfarmakokinetisk analyse af patienter med partielle anfald (aldersinterval fra 12 til 74 år) og primært generaliserede tonisk-kloniske anfald (aldersinterval fra 12 til 58 år), der fik perampanel op til 8 eller 12 mg/dag i placebokontrollerede kliniske studier, blev der ikke fundet nogen signifikant virkning af alder på perampanel-clearance. 
In a population pharmacokinetic analysis of patients with partial-onset seizures (age range 12 to 74 years) and primary generalised tonic-clonic seizures (age range 12 to 58 years), and receiving perampanel up to 8 or 12 mg/day in placebo-controlled clinical trials, no significant effect of age on perampanel clearance was found.
De puljede 50 %-responsrater var 19 % med placebo, 29 % med 4 mg, 35 % med 8 mg og 35 % med 12 mg. Der blev observeret en statistisk signifikant reduktion i anfaldshyppigheden efter 28 dage (baseline til behandlingsfasen), sammenlignet med placebogruppen, med perampanel-behandling ved doser på 4 mg/dag (studie 306), 8 mg/dag (studie 304, 305 og 306) og 12 mg/dag (studie 304 og 305). 
A statistically significant effect on the reduction in 28-day seizure frequency (Baseline to Treatment Phase) as compared to the placebo group was observed with perampanel treatment at doses of 4 mg/day (Study 306), 8 mg/day (Studies 304, 305 and 306), and 12 mg/day (Studies 304 and 305).
I en populationsfarmakokinetisk analyse af patienter med partielle anfald, der fik perampanel op til 12 mg/dag, og patienter med primært generaliserede tonisk-kloniske anfald, der fik perampanel op til 8 mg/dag, i placebokontrollerede kliniske studier, var perampanel-clearance hos kvinder (0,54 l/t) 18 % lavere end hos mænd (0,66 l/t). 
In a population pharmacokinetic analysis of patients with partial-onset seizures receiving perampanel up to 12 mg/day and patients with primary generalised tonic-clonic seizures receiving perampanel up to 8 mg/day in placebo-controlled clinical trials, perampanel clearance in females (0.54 l/h) was 18% lower than in males (0.66 l/h).
Flaske af polyethylenterephthalat (PET) med børnesikret polypropylen (PP) lukke. 
Polyethylene terephthalate (PET) bottle with a child-resistant (CR) polypropylene (PP) closure; each bottle contains 340 ml of suspension in an outer cardboard carton.
1,7 gange reduktion 
1.7 fold decrease
Afhængigt af individuel klinisk respons og tolerabilitet ved en dosis på 8 mg/dag, kan dosis øges med stigninger på 2 mg/dag til 12 mg/dag. 
Depending upon individual clinical response and tolerability at a dose of 8 mg/day, the dose may be increased by increments of 2 mg/day to 12 mg/day.
Fycompa 6 mg, 8 mg, 10 mg, 12 mg filmovertrukne tabletter 
Fycompa 6 mg, 8 mg, 10 mg, 12 mg film-coated tablets
Ændringerne i stemningslejet var små og afspejlede en generel reduktion i opmærksomheden. 
Mood deteriorated following dosing of 12 mg/day only; the changes in mood were small and reflected a general lowering of alertness.
Lægemiddelmetaboliserende enzyminduktion 
Drug metabolising enzyme inhibition
Mikrokrystallinsk cellulose Magnesiumstearat (E470b) 
Microcrystalline cellulose Magnesium stearate (E470b)
Et lignende resultat blev set i en populationsfarmakokinetisk analyse af patienter med partielle anfald, der fik perampanel op til 12 mg/dag, og hos patienter med primært generaliserede tonisk-kloniske anfald, der fik perampanel op til 8 mg/dag, i placebokontrollerede kliniske studier. 
A similar result was seen in a population pharmacokinetic analysis of patients with partial-onset seizures receiving perampanel up to 12 mg/day and patients with primary generalised tonic-clonic seizures receiving perampanel up to 8 mg/day in placebo-controlled clinical trials.
Patienter, der samtidig tager lægemidler, som ikke forkorter perampanels halveringstid (se pkt. 
Patients who are taking concomitant medicinal products that do not shorten the half-life of perampanel (see section 4.5) should be titrated no more frequently than at 2-week intervals.
Svære kutane bivirkninger (SCARs), herunder lægemiddelfremkaldt reaktion med eosinofili og systemiske symptomer (DRESS), som kan være livstruende eller dødelig, er rapporteret (hyppighed ikke kendt; se pkt. 
Severe cutaneous adverse reactions (SCARs) including drug reaction with eosinophilia and systemic symptoms (DRESS), which can be life-threatening or fatal, have been reported (frequency unknown; see section 4.8) in association with perampanel treatment.
2 mg tablet: Jernoxid, gul (E172), jernoxid, rød (E172) 4 mg tablet: Jernoxid, rød (E172) 
2 mg tablet: Ferric Oxide, Yellow (E172), Ferric Oxide, Red (E172) 4 mg tablet: Ferric Oxide, Red (E172)
Vend flasken om, og fjern den orale sprøjte. 
7 Turn upright and remove the oral syringe.
Hver ml oral suspension indeholder 0,5 mg perampanel. 
Each ml of oral suspension contains 0.5 mg perampanel
Fycompa 2 mg, 4 mg, 6 mg, 8 mg, 10 mg og 12 mg filmovertrukne tabletter Perampanel 
Fycompa 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg film-coated tablets Perampanel